Panagora Asset Management’s Kura Oncology KURA Stock Holding History

Panagora Asset Management’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-11,590	Closed	-$158K	–	1478
2022 Q3	$158K	Hold	11,590	–	–	﹤0.01%	1390
2022 Q2	$212K	Buy	+11,590	New	+$167K	﹤0.01%	1396
2021 Q3	–	Sell	-97	Closed	-$2K	–	2066
2021 Q2	$2K	Sell	97 -100	-51%	-$2.48K	﹤0.01%	2636
2021 Q1	$6K	Hold	197	–	–	﹤0.01%	2544
2020 Q4	$6K	Buy	+197	New	+$6.92K	﹤0.01%	2419
2017 Q3	–	Sell	-1,261	Closed	-$12K	–	2413
2017 Q2	$12K	Buy	+1,261	New	+$11.5K	﹤0.01%	2354
2017 Q1	–	Sell	-9,874	Closed	-$58K	–	2413
2016 Q4	$58K	Hold	9,874	–	–	﹤0.01%	2070
2016 Q3	$62K	Buy	+9,874	New	+$50K	﹤0.01%	2076

Other funds holding KURA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Panagora Asset Management's KURA Position: Q4 2022 in Review

Panagora Asset Management sold out of Kura Oncology (KURA) in Q4 2022, closing a stake of 11,590 shares — an estimated $158K sold.

Panagora Asset Management first reported a position in KURA in Q3 2016 and held it in 8 quarters. The position peaked at $212K in Q2 2022. 142 funds tracked by Wall St. Rank hold KURA as of Q4 2022.

Panagora Asset Management reported no remaining Kura Oncology position as of Q4 2022 after selling out during the quarter.
Panagora Asset Management sold 11,590 Kura Oncology shares in Q4 2022, an estimated $158K.
Panagora Asset Management first reported a position in Kura Oncology in Q3 2016 and held it in 8 quarters.
Panagora Asset Management's Kura Oncology position peaked at $212K in Q2 2022.
142 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2022.

Based on Panagora Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.